The widespread use of acetaminophen during pregnancy may carry previously underestimated neurodevelopmental risks for children, challenging current safety assumptions about this commonly recommended pain reliever. Nearly half of pregnant women receive acetaminophen prescriptions, making any developmental impact a significant public health concern.
This comprehensive analysis of over 2 million births in Taiwan revealed measurable associations between maternal acetaminophen prescriptions and subsequent ADHD and autism spectrum disorder diagnoses in children. Among the cohort, 48.3% of mothers received at least two acetaminophen prescriptions during pregnancy, with 116,387 children later diagnosed with ADHD and 23,557 with autism spectrum disorders. The study tracked prescription records through Taiwan's national health database, providing unusually robust exposure data compared to typical recall-based studies.
This finding adds substantial weight to growing concerns about acetaminophen's neurodevelopmental effects, building on smaller European studies that suggested similar associations. The large sample size and sibling-comparison methodology help address confounding factors that have limited previous research. However, the observational design cannot establish direct causation, and the study cannot account for underlying maternal conditions requiring pain management or other unmeasured variables that might influence both acetaminophen use and neurodevelopmental outcomes. The research represents a significant contribution to an evolving debate about pregnancy medication safety, though it stops short of definitively proving acetaminophen causes these conditions. For expectant mothers, this data adds complexity to risk-benefit calculations about pain management during pregnancy.